Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) FCF Payout Ratio (2023 - 2024)

Guided Therapeutics' FCF Payout Ratio history spans 2 years, with the latest figure at 0.26 for Q2 2024.

  • On a quarterly basis, FCF Payout Ratio changed N/A to 0.26 in Q2 2024 year-over-year; TTM through Jun 2024 was 0.11, a 209.28% decrease, with the full-year FY2023 number at 0.04, up 52.99% from a year prior.
  • FCF Payout Ratio hit 0.26 in Q2 2024 for Guided Therapeutics, up from 0.65 in the prior quarter.
  • Over the last five years, FCF Payout Ratio for GTHP hit a ceiling of 0.13 in Q1 2023 and a floor of 0.65 in Q1 2024.